KNE Share Price

Open 0.13 Change Price %
High 0.13 1 Day 0.00 0.00
Low 0.13 1 Week 0.00 0.00
Close 0.13 1 Month -0.02 -13.33
Volume 10500 1 Year 0.09 225.00
52 Week High 0.18
52 Week Low 0.02
KNE Important Levels
Resistance 2 0.13
Resistance 1 0.13
Pivot 0.13
Support 1 0.13
Support 2 0.13
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
AVC 0.02 100.00%
WMR 0.02 100.00%
BVQ 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
TUF 0.02 100.00%
ROI 0.02 100.00%
DDX 0.50 100.00%
MOO 0.02 100.00%
RDM 0.21 90.91%
More..
CVE Canada Top Losers Stocks
ADE 0.00 -100.00%
KLM 0.01 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Kane Biotech Inc (CVE: KNE)

KNE Technical Analysis 3
As on 26th Apr 2017 KNE Share Price closed @ 0.13 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.04 & Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
KNE Target for April
1st Target up-side 0.21
2nd Target up-side 0.27
3rd Target up-side 0.33
1st Target down-side 0.05
2nd Target down-side -0.01
3rd Target down-side -0.07
KNE Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.kanebiotech.com
KNE Address
KNE
162-196 Innovation Drive
Winnipeg, MB R3T 2N2
Canada
Phone: 204-453-1301
Fax: 204-474-7552
KNE Latest News
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding ...   Yahoo Finance   - 28th Mar 17
Biotech firm's pet project   Winnipeg Free Press   - 07th Mar 17
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra   Marketwired (press release)   - 06th Mar 17
Philip Renaud Files Early Warning Report in Respect of Kane Biotech Inc.   Marketwired (press release)   - 06th May 16
Kane Biotech Announces Rights Offering   Marketwired (press release)   - 30th Mar 16
City biotech firm hopes to take bite out of pet-care industry in US   Winnipeg Free Press   - 15th Mar 16
Kane Biotech Expanding Bluestem to the US   PetProductNews.com   - 03rd Mar 16
Ahrens-Townsend named new CEO of Kane Biotech   Winnipeg Free Press   - 12th May 15
Kane Biotech Introduces bluestemâ„¢   Marketwired (press release)   - 12th Feb 15
Kane Biotech Appoints Dr. Sarah Prichard, MD to the Board of Directors   Marketwired (press release)   - 02nd Apr 14
Interactive Technical Analysis Chart Kane Biotech Inc ( KNE CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Kane Biotech Inc
KNE Business Profile
Kane Biotech Inc., a biotechnology company, is engaged in the development and commercialization of products to prevent and remove biofilms. Its products include DispersinB, an antibiofilm enzyme for the wound care market; Aledex for the medical device coating market; KBI antibacterial disinfectant; and StrixNB for the oral care market. The company was founded in 2001 and is based in Winnipeg, Canada.